Utama › Mieloma Pelbagai › New York › Queens
Kajian klinikal Mieloma Pelbagai di Queens, NY
20 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Queens (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 3
- NYU Winthrop, Mineola · 11 mi jauh
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Mengambil pesertaFasa 3
- Northwell Health Cancer Institute, Lake Success · 9 mi jauh
- NYU Langone Hospital Long Island, Mineola · 11 mi jauh
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Mengambil pesertaFasa 3
- MSK Nassau, Uniondale · 13 mi jauh
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- Queens Cancer Center, Rego Park · 3 mi jauh
- Cohen Children's Medical Center, New Hyde Park · 9 mi jauh
- Northwell Health Monter Cancer Center, Lake Success · 9 mi jauh
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Mengambil pesertaFasa 3
- Long Island Jewish Medical Center, New Hyde Park · 9 mi jauh
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi jauh
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Mengambil pesertaFasa 3
- MSK Nassau, Uniondale · 13 mi jauh
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Mengambil pesertaFasa 3
- Research Site, New Hyde Park · 9 mi jauh
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Mengambil pesertaKajian pemerhatian
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mi jauh
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Mengambil pesertaFasa 1/2
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauh
A Dietary Study for People With Multiple Myeloma
Mengambil peserta
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauh
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Memorial Sloan Kettering Rockville, Rockville Centre · 10 mi jauh
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Mengambil peserta
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauh
Kajian Mieloma Pelbagai di bandar lain
- New York City, NY60 kajian
- Boston, MA42 kajian
- Atlanta, GA41 kajian
- Houston, TX38 kajian
- Durham, NC37 kajian
- Nashville, TN32 kajian
- Denver, CO27 kajian
- Rochester, MN24 kajian
- St. Louis, MO24 kajian
- Columbus, OH24 kajian
- Baldwin Park, CA23 kajian
- Chicago, IL22 kajian
Kajian lain di Queens
- Kanser Payudara63 kajian
- Kanser Paru-paru Bukan Sel Kecil49 kajian
- Kanser Kolorektal31 kajian
- Kanser Metastatik28 kajian
- Kanser Ovari28 kajian
- Kanser Prostat27 kajian
- Kanser (semua jenis)26 kajian
- Kanser Endometrium25 kajian
- Kanser Paru-paru22 kajian
- Leukemia Mieloid Akut21 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher20 kajian
- Kanser Pankreas20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.